In-office balloon sinus dilation vs medical therapy for recurrent acute rhinosinusitis
- Posted on: Dec 6 2018
Summary: In this randomized controlled study, we evaluated 24-week outcomes for in-office balloon sinus dilation (BSD) performed in office with medical management (MM) as compared with medical management only for patients with recurrent acute sinusitis.
To read the full publication, please click on the following link: IFAR Article IO BSD vs Med Therapy For RARS Nov 2018
Posted in: Publications
The comments are closed.